AI-Based Health Coaching Aids Blood Pressure Management
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, June 12, 2024 -- Artificial intelligence (AI)-based, lifestyle coaching can improve blood pressure (BP) management, according to a study published online May 28 in JMIR Cardio.
Jared Leitner, from the University of California, San Diego (UCSD), and colleagues assessed the effectiveness of a fully digital, autonomous, and AI-based lifestyle coaching program on achieving BP control among adults with hypertension. The analysis included 141 participants monitored over 24 weeks with data from wearable activity trackers, BP monitors, and mobile app questionnaire responses.
The researchers found that at 12 weeks, systolic and diastolic BP decreased by 5.6 and 3.8 mm Hg, respectively. Systolic and diastolic BP decreased by even more for participants starting with stage 2 hypertension (9.6 and 5.7 mm Hg, respectively). Systolic and diastolic BP decreased by 8.1 and 5.1 mm Hg, respectively, at 24 weeks. For participants with stage 2 hypertension, systolic and diastolic BP decreased by 14.2 and 8.1 mm Hg, respectively, at 24 weeks. From baseline to 12 and 24 weeks, the percentage of participants with controlled BP increased by 17.2 and 26.5 percent, respectively. From baseline to 12 and 24 weeks, the percentage of participants with stage 2 hypertension decreased by 25 and 26.5 percent, respectively.
"By pinpointing the top lifestyle contributors to patients’ hypertension and providing precise guidance, the AI-powered lifestyle coaching was able to maintain high patient engagement leading to improved patient outcomes," Leitner said in a statement.
Several of the authors are cofounders of CIPRA.ai Inc, a start-up company formed out of UCSD, which has licensed the intervention technology presented in this paper.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-13 01:15
Read more
- ACAAI: Most Syphilis Patients With Penicillin Allergy Have Low Risk for Severe Allergy
- FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
- American Society of Anesthesiologists, Oct. 18 to 22
- Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
- Syndax Announces Positive Pivotal Topline Results from Relapsed or Refractory mNPM1 AML Cohort in AUGMENT-101 Trial of Revumenib
- Measures of Social Support Linked to Cancer Screening
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions